Regeneron Pharmaceuticals, Inc.

Amova Asset Management Americas, Inc. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

16,171

Value ($000)

12,482

Weight

0.1%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	12,482	0.1%	16,171	12/31/2025
2025 Q3	11/12/2025	11,371	0.1%	20,224	9/30/2025
2025 Q2	8/11/2025	12,229	0.1%	23,314	6/30/2025
2025 Q1	5/7/2025	15,311	0.2%	24,164	3/31/2025
2024 Q4	2/10/2025	18,630	0.2%	26,154	12/31/2024
2024 Q3	11/7/2024	30,368	0.3%	28,884	9/30/2024
2024 Q2	8/9/2024	32,579	0.4%	30,997	6/30/2024
2024 Q1	5/2/2024	32,043	0.3%	33,305	3/31/2024
2023 Q4	2/8/2024	30,740	0.3%	35,019	12/31/2023
2023 Q3	11/9/2023	30,236	0.4%	36,752	9/30/2023
2023 Q2	8/14/2023	27,524	0.3%	38,304	6/30/2023
2023 Q1	5/3/2023	30,612	0.4%	38,325	3/31/2023
2022 Q4	2/13/2023	29,958	0.4%	41,525	12/31/2022
2022 Q2	8/4/2022	30,014	0.4%	54,570	6/30/2022
2022 Q1	5/6/2022	47,081	0.3%	69,237	3/31/2022
2021 Q4	2/8/2022	58,038	0.3%	91,320	12/31/2021
2021 Q3	11/9/2021	70,253	0.3%	121,872	9/30/2021
2021 Q2	8/9/2021	87,100	0.3%	157,513	6/30/2021
2021 Q1	5/3/2021	37,670	0.2%	79,618	3/31/2021
2020 Q4	2/11/2021	26,048	0.1%	53,918	12/31/2020
2020 Q3	11/2/2020	15,918	0.1%	28,372	9/30/2020
2020 Q2	8/7/2020	21,335	0.3%	35,012	6/30/2020
2020 Q1	4/30/2020	30,101	0.6%	61,646	3/31/2020
2019 Q4	2/6/2020	54,528	0.9%	145,223	12/31/2019